Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Biomolecules|October 2, 2020
Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical TranslationJessica Bridoux, Katrijn Broos, Quentin Lecocq, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 5, 2024
Efficient α and β<sup>-</sup> radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour modelHannelore Ceuppens, Ana Rita Pombo Antunes, Laurent Navarro, et al.
Frontiers in Immunology|March 26, 2021
Immunogenicity Risk Profile of NanobodiesChloé Ackaert, Natalia Smiejkowska, Catarina Xavier, et al.
Journal of Translational Medicine|September 7, 2019
Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapyTeofila Seremet, Yanina Jansen, Simon Planken, et al.
Molecular Imaging and Biology|January 24, 2019
Clinical Translation of [<sup>68</sup>Ga]Ga-NOTA-anti-MMR-sdAb for PET/CT Imaging of Protumorigenic MacrophagesCatarina Xavier, Anneleen Blykers, Damya Laoui, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 9, 2014
Genome-wide computational analysis reveals cardiomyocyte-specific transcriptional Cis-regulatory motifs that enable efficient cardiac gene therapyMelvin Y Rincon, Shilpita Sarcar, Dina Danso-Abeam, et al.
Cancers|April 25, 2020
Preclinical Targeted α- and β<sup>-</sup>-Radionuclide Therapy in HER2-Positive Brain Metastasis Using Camelid Single-Domain AntibodiesJanik Puttemans, Yana Dekempeneer, Jos L Eersels, et al.
Molecular Cancer Therapeutics|October 20, 2021
The Road to Personalized Myeloma Medicine: Patient-specific Single-domain Antibodies for Anti-idiotypic Radionuclide TherapyJanik Puttemans, Benoit Stijlemans, Marleen Keyaerts, et al.
Molecular Therapy. Methods & Clinical Development|September 6, 2021
Formatting and gene-based delivery of a human PD-L1 single domain antibody for immune checkpoint blockadeRobin Maximilian Awad, Quentin Lecocq, Katty Zeven, et al.
Molecular Cancer Therapeutics|May 2, 2022
Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma ModelThomas Ertveldt, Lien De Beck, Kirsten De Ridder, et al.
Pageof 7